Birchview Capital as of Dec. 31, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 48 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 28.4 | $49M | 794k | 62.03 | |
| Biodesix (BDSX) | 12.8 | $22M | 1.1M | 20.16 | |
| Accelr8 Technology | 9.6 | $17M | 2.2M | 7.58 | |
| Quidel Corporation | 6.1 | $11M | 59k | 179.64 | |
| Neurocrine Biosciences (NBIX) | 4.4 | $7.7M | 80k | 95.85 | |
| Foghorn Therapeutics (FHTX) | 3.7 | $6.4M | 314k | 20.27 | |
| Aspira Womens Health | 3.2 | $5.6M | 840k | 6.69 | |
| ACADIA Pharmaceuticals (ACAD) | 3.1 | $5.5M | 102k | 53.46 | |
| Albireo Pharma | 2.0 | $3.5M | 92k | 37.51 | |
| Oxford Immunotec Global | 1.7 | $3.0M | 170k | 17.46 | |
| Biogen Idec (BIIB) | 1.7 | $3.0M | 12k | 244.88 | |
| Karyopharm Therapeutics | 1.7 | $2.9M | 188k | 15.48 | |
| United Therapeutics Corporation (UTHR) | 1.6 | $2.7M | 18k | 151.78 | |
| Bluebird Bio | 1.5 | $2.7M | 62k | 43.27 | |
| Acceleron Pharma | 1.4 | $2.4M | 19k | 127.95 | |
| Masimo Corporation (MASI) | 1.2 | $2.1M | 8.0k | 268.38 | |
| Chemocentryx | 1.1 | $1.9M | 30k | 61.93 | |
| Arena Pharmaceuticals | 1.0 | $1.7M | 22k | 76.82 | |
| Soleno Therapeutics | 0.9 | $1.6M | 827k | 1.93 | |
| Amarin Corp Spons Adr New | 0.8 | $1.5M | 300k | 4.89 | |
| Progenity | 0.8 | $1.3M | 250k | 5.31 | |
| Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.3M | 50k | 26.16 | |
| Arvinas Ord (ARVN) | 0.7 | $1.3M | 15k | 84.93 | |
| Stoke Therapeutics (STOK) | 0.7 | $1.2M | 20k | 61.95 | |
| Harrow Health (HROW) | 0.7 | $1.2M | 180k | 6.86 | |
| ImmunoGen | 0.7 | $1.2M | 190k | 6.45 | |
| Equitrans Midstream Corp (ETRN) | 0.6 | $1.1M | 133k | 8.04 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $1.1M | 80k | 13.14 | |
| Contrafect | 0.6 | $1.0M | 200k | 5.05 | |
| Amicus Therapeutics (FOLD) | 0.5 | $877k | 38k | 23.08 | |
| Biohaven Pharmaceutical Holding | 0.5 | $857k | 10k | 85.70 | |
| Tg Therapeutics (TGTX) | 0.4 | $780k | 15k | 52.00 | |
| Bmy Cvr Rts 03/31/21 Right | 0.4 | $763k | 1.1M | 0.69 | |
| G1 Therapeutics | 0.4 | $720k | 40k | 18.00 | |
| Progyny (PGNY) | 0.4 | $636k | 15k | 42.40 | |
| Continental Resources | 0.4 | $629k | 39k | 16.30 | |
| Inari Medical Ord | 0.4 | $611k | 7.0k | 87.29 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $570k | 30k | 19.00 | |
| Translate Bio | 0.3 | $553k | 30k | 18.43 | |
| Xencor (XNCR) | 0.3 | $537k | 12k | 43.66 | |
| Encana Corporation (OVV) | 0.3 | $493k | 34k | 14.35 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $458k | 8.0k | 57.25 | |
| Pioneer Natural Resources | 0.2 | $433k | 3.8k | 113.95 | |
| Odonate Therapeutics Ord | 0.2 | $384k | 20k | 19.20 | |
| Inflarx Nv (IFRX) | 0.2 | $352k | 70k | 5.03 | |
| Dicerna Pharmaceuticals | 0.1 | $220k | 10k | 22.00 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $149k | 20k | 7.45 | |
| Yield10 Bioscience | 0.1 | $110k | 19k | 5.80 |
